Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists
Johannes F.E. Mann, Marcel H.A. Muskiet
Topics & Concepts
MedicineType 2 diabetesDiabetes mellitusIncretinInternal medicineGlycated hemoglobinInsulin resistanceLixisenatideExenatideIntensive care medicineEndocrinologyDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer